Overexpression of hnRNPA2/Bl in bronchoscopic specimens: A potential early detection marker in lung cancer

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1373-1382

  Katsimpoula, S ^a   Patrinou Georgoula, M ^b   Makrilia, N ^a   Dimakou, K ^a   Guialis, A ^b   Orfanidou, D ^a   Syrigos, K N ^a,c  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Biomarker; Brushing; Hnrnpa2 bl; Immunoblotting; Lung cancer

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOPSY; BRONCHOSCOPY; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EARLY DIAGNOSIS; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 64949195392     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Alberts WM: Lung Cancer Guidelines. Introduction. CKest 123( 1 Suppl): 1S-2S, 2003.
2. ScKmidt B, Carstensen T, Engel E, Jandrig C, Witt C and FleiscKKacker M: Detection of cell-free nucleic acids in broncKial lavage fluid supernatants from patients witK lung cancer. Eur J Cancer 40(3): 452-460, 2004.
3. Spiro SG and Porter J: Lung cancer - WKere are we today? Current advances in staging and nonsurgical treatment. State of tKe Art. Am J Respir Crit Care Med 166(9): 1166-96, 2002.
4. Sueoka E, Goto Y, Sueoka N, kai Y, kozu T and Fujiki K: Keterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for Kuman lung cancers. Cancer Res 59(7): 1404- 1407, 1999.
5. Carpenter B, Mackay C, Alnabulsi A, Mackay M, Telfer C, Melvin WT and Murray GI: TKe roles of Keterogeneous nuclear ribonucleoproteins in tumor development and progression. BiocKim BiopKys Acta 1765(2): 85-100, 2006.
6. ZKou J, Nong L, WlocK M, Cantor A, MulsKine JL and Tockman MS: Expression of early lung cancer detection marker: KnRNP- A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. Lung Cancer 34(3): 341-350, 2001.
7. Fielding P, Turnbull L, Prime W, WalsKaw M and Filed Jk: Keterogeneous nuclear ribonucleoprotein A2/B1. Up-regulation in broncKial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 5(12): 4048-4052, 1999.
8. Kilbe W, DirnKofer ST, Greil R and Wö11 E: Biomarkers in non- small cell lung cancer prevention. Eur J Cancer Prev 13: 425- 436, 2004.
9. ZKou J, MulsKine JL, Ro JY, Avis I, Yu R, Lee JJ, Morice R, Lippman SM and Lee JS: Expression of Keterogeneous nuclear ribonucleoprotein A2/B1 in broncKial epitKelium of cKronic smokers. Clin Cancer Res 4(7): 1631-1640, 1998.
10. Sueoka E, Sueoka N, Goto Y, Matsuyama S, NisKimura K, Sato M, Fujimura S, CKiba K and Fujiki K: Keterogeneous nuclear ribonucleoprotein Bl as early cancer biomarker for occult cancer of Kuman lungs and dysplasia. Cancer Res 61(5): 1896-1902, 2001.
11. Wu S, Sato M, Endo C, Sakurada A, Dong B and Aikawa K, CKen Y, Okada Y, Matsumara Y, Sueoka E and kondo T: KnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of tKe lung. Lung Cancer 41(2): 179-186, 2003.
12. Goto Y, Sueoka E, CKiba K and Fujiki K: Significance of Keterogeneous nuclear ribonucleoprotein Bl as a new early detection marker for oral squamous cell carcinoma. Jpn J Cancer Res 90(12): 1358-1363, 1999.
13. Tani K, OKsKima k, Karaoka S, KAmasaki M, kaamma K, Ikeda S and kikucKi M: Overexpression of Keterogeneous nuclear ribonucleoprotein Bl in lympKoproliferative disorders: KigK expression in cells of follicular center origin. Int J Oncol 21(5): 957-963, 2002.
14. kamma K, KorigucKi K, Wan L, Matsui M, Fujiwara M, Fujimoto M, Yazawa T and Dreyfuss G: Molecular cKaracterization of tKe KnRNP A2/B1 proteins: Tissue-specific expression and novel isoforms. Exp Cell Res 246(2): 399-411, 1999.
15. Tockman MS, MulsKine JL, Piantadosi S, Erosan YS, Gupta Pk, RuckdescKel JC, Taylor PR, ZKukov T, ZKou WK, Qiao YL and Yao SX: Prospective detection of preclinical lung cancer: Results from two studies of Keterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 3(12 Pt 1): 2237-2246,1997.
16. ScKmidt B, Engel E, Carstensen T, Weicmann S, JoKn M, Witt C and FleiscKKack;er M: Quantification of free RNA in serum and broncKial lavage: a new diagnostic tool in lung cancer detection? Lung Cancer 48(1): 145-147, 2005.
17. Sueoa E, Sueoappa;a N, Iwanaga k, Sato A, Suga K, KayasKi S, Nagasawa k and NakasKi k: Detection of plasma KnRNP Bl, a new cancer biomarker, in lung cancer patients by quantative real-time polymerase cKain reaction. Lung Cancer 48(1): 77- 83,2005.
18. kamma K, KorigucKi K, Wan L, Matsui M, Fujiwara M, Fujimoto M, Vazawa T and Dreyfuss G: Molecular cKaracterization of tKe KnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp Cell Res 246(2): 399-411, 1999.
19. Travis WD, Colby TV, Corrin B, SKimosato Y and Brambilla E: Kistological Typing of Lung and Pleural Tumors. World KealtK Organization. International Kistological Classification of Tumours. 3rd ed. Berlin, Springer-Verlag, 1999.
20. Mountain CF: A new international staging system for lung cancer. CKest 89(4 Suppl): 225s-233s, 1986.
21. Spiro SG: Lung Cancer. Eur Respir Mon 17: 105-115, 2001.
22. Issaq KJ and Veenstra TD: TKe role of electropKoresis in disease biomarker discovery. ElectropKoresis 28(12): 1980-1988, 2007.
23. Egger D and Bienz k: Protein (western) blotting. Mol BiotecKnol 1(3): 289-305, 1994.
24. Boiling D, Brown L and Aquino A: Anomaly in western blot band intensities perceived by visual inspection. Appl TKeor ElectropKor 1(3): 161-162, 1989.
25. SmitK BJ: Quantification of proteins on polyacrylamide gels (nonradioactive). MetKods Mol Biol 32: 107-111, 1994.
26. Roggli VL, Vollmer RT, Greenberg SD, McGravran MK, Spjut KJ and Yener R: Lung cancer Keterogeneity: A blinded and randomized study of 100 consecutive cases. Kum PatKol 16(6): 569-579, 1985.
27. Kamasaki M, kamma K, Wu W, kaneko S, Fujiwara M, SatoK K, Karaoka S, kikucKi M and SKirakusa T: Expression of KnRNP A2/B1 in four major Kistological types of lung cancer. Anticancer Res 21(2A): 979-984, 2001.
28. FleiscKKacker M, Beinert T, ErmitscK M, Seferi D, Possinger k, Engelmann C and Jandrig B: Detection of amplifiable messenger RNA in tKe serum of patients witK lung cancer. Annals NY Acad Sci 945: 179-188,2001.
29. SlaugKter DP, SoutKwick KW and Smejkal W: Field cancerization in oral stratified squamous epitelium. Cancer 6(5): 963-968, 1953.
30. Pino I, Pio R, Toledo G, Zabalegui N, Vicent S, Rey N, Lozano MD, Torre W, Garcia-Foncillas J and Montuenga LM: Altered patterns of expression of members of tKe Keterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 41(2): 131-143,2003.
31. Snead DR, Perunovic B, Cullen N, NeedKam M, DKillon DP, SatoK K and kamma K: KnRNP Bl expression in benign and malignant lung disease. J PatKol 200(1): 88-94, 2003.
32. Garayoa M, Man YG, Martinez A, Cuttitta F and MulsKine JL: Down-regulation of KnRNP A2/B1 expression in tumor cells under prolonged Kypoxia. Am J Respir Cell Mol Biol 28(1): 80- 85, 2003.
33. kopreski MS, Benko FA, kwak LW and Gocke CD: Detection of tumor messenger RNA in tKe serum of patients witK malignant melanoma. Clin Cancer Res 5(8): 1961-1965, 1999.
34. CKen XQ, Bonnefoi K, Pelte MF, Lyautey J, Lederrey C, MovarekKi S, ScKaeffer P, MulcaKy KE, Meyer P, Stroun M and Anker P: Telomerase RNA as a detection marker in tKe serum of lung cancer patients. Clin Cancer Res 6(10): 3823-3826, 2000.